GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.320
-0.040 (-2.94%)
At close: Jun 11, 2025, 4:00 PM
1.340
+0.020 (1.52%)
Pre-market: Jun 12, 2025, 7:39 AM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.10 million as of June 12, 2025. Its market cap has increased by 98.76% in one year.
Market Cap
3.10M
Enterprise Value
-74.60K
1-Year Change
98.76%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $3.10M, a decrease of -87.79%. That is a compound annual growth rate of -62.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 3.19M | -56.86% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.64B |
| Johnson & Johnson | 376.43B |
| Novo Nordisk | 353.20B |
| AbbVie | 334.73B |
| UnitedHealth Group | 275.58B |
| Abbott Laboratories | 233.36B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |